Ethyl 2- (4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161797-99-5 Febuxostat Tsabtace Tsabtace>99.0% Factory
Ruifu Chemical Supply Febuxostat Matsakaici masu dangantaka:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2- (3-Cyano-4-Hydroxyphenyl) -4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2- (3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2- (3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2- (3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2- (4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Sunan Sinadari | Ethyl 2- (4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate |
Makamantu | Febuxostat Intermediate |
Lambar CAS | 161797-99-5 |
Lambar CAT | Saukewa: RF-PI1122 |
Matsayin Hannun jari | A hannun jari, Ƙarfin Samar da Ton 100/shekara |
Tsarin kwayoyin halitta | Saukewa: C13H13NO3S |
Nauyin Kwayoyin Halitta | 263.31 |
Matsayin narkewa | 180 ℃ |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Rawaya Mai Haske zuwa Kashe-Farin Foda |
Ganewa | Ta HPLC;By HNMR |
Asara akan bushewa | <0.50% |
Ragowa akan Ighition | <0.30% |
Rashin Tsabtace Guda Daya | <0.50% |
Jimlar ƙazanta | <1.00% |
Tsarkake / Hanyar Bincike | > 99.0% (na HPLC) |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaicin Febuxostat (CAS: 144060-53-7) |
Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi
Ethyl 2- (4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate (CAS: 161797-99-5) ana amfani dashi a cikin haɗin Febuxostat (CAS: 144060-53-7), xanthine oxidase / xanthine dehydrogenase inhibitor.Ana amfani dashi don maganin hyperuricemia da gout na kullum.An tabbatar da 40-120 MG / rana febuxostat mai tasiri a rage yawan matakan urate na jini lokacin da aka gudanar don sarrafa hyperuricemia a cikin marasa lafiya tare da gout.Teijin Pharmaceuticals ne ya gano Fabuxostat kuma an ba shi lasisi zuwa TAP Pharmaceuticals (wanda a halin yanzu wani ɓangare ne na Takeda Pharmaceuticals) kuma an yarda dashi a Amurka don maganin hyperuricemia a cikin marasa lafiya tare da gout.